Printer Friendly

In Vitro Antioxidant and Antimicrobial Activities of Ephedra gerardiana (Root and Stem) Crude Extract and Fractions.

1. Introduction

The northern areas of Pakistan are considered to be rich in biodiversity and contain more than 400 species of medicinal plant species including genus ephedra, which is evergreen gymnosperm, belonging to family Ephedraceae [1]. Mahuang is the drug isolated from Ephedra, used in Chinese medicine for 5000 year to cure various human diseases such as fever, nasal congestion, and asthma [2]. In Japan, ephedra genus is used at a rate of some 300 tons a year due to their addition as a crude drug in several Sino-Japanese medicine; preparations have been widely used as a treatment for fever, nasal congestion, and asthma [3]. Furthermore, the ephedra genus contains bronchial dilator, ephedrine, and other ephedrine alkaloids. It has been also used for many years in traditional medicine to treat allergies, bronchial asthma, chills, colds, coughs, edema, fever, flu, headaches, and nasal congestion and has been a natural source of alkaloids such as ephedrine, pseudoephedrine, pseudoephedrine, and other related compounds [4]. Similarly, the extracts with various chemicals from medicinal plants have been tested and showed the effectiveness of traditional herbs against microorganisms; as a result plants are one of the bedrocks for modern medicine to attain new principles [5]. Thus, medicinal plants can offer a wealth for their biological activities, such as antimicrobial, antioxidants, antimalarial, and anticancer activities.

Therefore, the exploration of plants needs attention to isolate compounds that can act as suitable antioxidants and antimicrobial agent instead of synthetic compounds [6]. Recently, the natural antioxidants have significantly increased in food and cosmetic and therapeutic products, since they have multifacetedness in their mass and amount of activities and provide huge scope in modifying imbalance [7]. Similarly, the aqueous extract of the Ephedra aphylla is used as strong inhibiter against malarial parasitic protozoan, plasmodium falciparum [8], and the compounds which were isolated from Ephedra aphylla have no estrogenic activity but most of the Lignans exhibited moderate antioxidant activity without any cytotoxicity. Up to now, some species of genus ephedra were screened for antimicrobial activities including, E. altissima [9], E. transitoria [10], E. breana [11], and E. gerardiana (leaf) [12], while, as for their antioxidant potential, E. laristanica, E. sarcocarp [13], and E. gerardiana (ethanol extract) [14] were investigated. In the light of this previous study, we sought to evaluate the crude extracts and fractions of E. gerardiana (root and stem) for free radical scavenging potential and antimicrobial (fungal and bacterial) activities.

2. Materials and Methods

2.1. Plant Material. Ephedra gerardiana was collected from the Kaghan valley of Khyber Pakhtunkhwa, Pakistan (Figure 1), and plant specimen was deposited with the voucher number 3550 in herbarium of Hazara University, Mansehra, Pakistan.

2.2. Extraction and Fraction. Collected plant materials (root and stem) were dried at room temperature and grinded into fine powder. The powdered plant materials were soaked in methanol (commercial grade) for 12 days three times. The extract was filtered using filter paper and residue plant materials were soaked again in methanol and solvent was vaporized at 40[degrees]C through rotary evaporator [15]. The process was repeated three times and the methanol crude extract was obtained. The crude methanolic extract was suspended in distilled water with constant stirring and fractionated with n-hexane, chloroform (CHCl3), ethyl acetate (EtOAc), and n-butanol, respectively [16]. The solvents were evaporated at 40[degrees]C through rotary evaporator and different fractionations were obtained.

2.3. Chemicals. Propyl gallate (PG), 1,1-diphenyl-2-picrylhydrazyl (DPPH), 3-tert-butyl-4-hydroxyanisole (TBH), dimethyl sulfoxide (DMSO), sabouraud dextrose agar (SDA), nutrient agar, and nutrient broth. All chemicals and reagents were purchased from Merck (Germany) and Sigma-Aldrich (USA).

2.4. Stock Solution Preparation. Methanolic crude extracts and different fractions (n-hexane, chloroform, ethyl acetate, and n-butanol) of the plants were dissolved in dimethyl sulfoxide (DMSO) with the concentration of 1 mg/ml being evaluated for biological potential [17].

2.5. Antioxidant Activity (DPPH Assay). Plants extracts were examined for their antioxidant activity on the basis of scavenging effects using stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) method [18]; freshly DPPH solution was prepared and kept in the dark at 4[degrees]C. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) (3.2 [micro]l) was dissolved in 25 ml methanol with steering regularly up to 30 minutes. Methanolic solutions of DPPH (90 [micro]l) were added to 10 [micro]l of plants extracts solution with different concentration. The mixture was incubated for 30 minutes at 37[degrees]C at room temperature; after incubation the absorbance was measured at 490 nm using multiplate reader (Bio-Tek Elx800[TM], Instruments, Inc., USA). Propyl gallate (PG) and 3-tert-butyl-4-hydroxyanisol (TBH) were used as standard whereas dimethyl sulfoxide (DMSO) was used as negative control. Every determination was performed in triplicate. Percentage inhibition of the radical scavenging activity of test samples was calculated according to [19].

Percent (%) inhibition of DPPH activity

= [(Ab - Aa)/Ab] x 100, (1)

where Aa is absorbance values of the test sample, while Ab is absorbance value of blank sample. Extracts concentration providing 50% inhibitions ([IC.sub.50]) was calculated from the graph plotted of inhibition percentage against extracts concentration. All tests were carried out in triplicate.

2.6. Antifungal Assay (Pour Plate Method). Antifungal activities of plants crude extract and fraction were determined by pour plate method [20]. Media were prepared by dissolving 65 g of sabouraud dextrose agar (SDA) media in 1000 ml of distilled water. Prepared media were autoclaved for 20 min at 121[degrees]C and Petri plates and tips were also autoclaved. Two strains of fungus were used such as Aspergillus niger and Aspergillus flavus and sample was prepared by dissolving 1 mg/ml in DMSO while 25 ml of media was poured in each Petri plate. Media were allowed to solidify and spores of fungus were applied in the center of the plate. Sterile paper discs were placed in front of the growing end of the mycelium. Samples were applied on the sterile paper discs; each sample was applied in triplicate. The culture was allowed to grow for four to seven days at 26[degrees]C. Fluconazole was used as standard and (DMSO) as negative control. Crescent shape of fungi appeared in front of paper discs, showing an inhibition. Zone of inhibition was measured according to [21].

% Inhibition of fungal growth

= 100 - linear growth in test (mm)/linear growth in control (mm) x 100. (2)

2.7. Antibacterial Assay (Disc Diffusion Method). Antibacterial activities of the plants crude extracts and different fraction were determined by using paper disc diffusion method [20]. Media were prepared by dissolving 28 g of nutrient agar and 13 g of nutrient broth in 1000 ml of distilled water in flask. The nutrient broth was taken approximately 7-8 ml per test tube. All apparatus and media, namely, Petri plates, tips, Whitman filter paper disc, normal saline, and so on used in activity, were autoclaved for 20 min at 121[degrees]C. After sterilization nutrient agars were poured into the Petri plates in laminar flow hood, allowed to solidify, and placed in the incubator at 37[degrees]C to avoid any contamination. The bacterial stock cultures were freshened on the nutrient agar plates by streaking with sterile inoculation loop in laminar flow hood; cultures were incubated at 37[degrees]C for 24 hours. The bacterial cultures were inoculated into the sterilized nutrient broth in the flask containing approximately 20-25 ml broth media and were, then, incubated in the shaking water bath (Model GLSC-SBR-04-28) for 16 hours at 200 rpm at 37[degrees]C. The bacterial cultures from flask were diluted in test tube containing sterilized nutrient broth for standardization by comparing with 0.5 McFarland (turbidity) standards. 50 [micro]l of standardized bacterial culture was spread on each nutrient ager plate with the help of glass spreader. These impregnated plates were refrigerated for 10 mints for absorption, after refrigeration impregnated plates were brought to laminar flow to place the filter paper disc (6 mm in diameter) with the help of sterilized forceps. The samples (6[micro]ml) were applied on each paper disc. Azithromycin and tetracycline were applied on separate plates as positive control for both bacteria while DMSO was used as negative control. The plates were incubated at 37[degrees]C for 24 hours; zone of inhibition was recorded around each paper disc in mm. All tests were applied in triplicate.

2.8. Statistical Analysis. All experimental data of antioxidants, antifungal, and antibacterial activities were statistically express as mean [+ or -] standard deviation (SD). The measurements are replicated three times. The [IC.sub.50] values for antioxidants were calculated from linear regression analysis using Graph pad prism5 software.

3. Results and Discussion

3.1. Antioxidant Activities. The crude extract and their fraction of root and stem of E. gerardiana were investigated for free radical scavenging activities. The [IC.sub.50] values with 2.96 [+ or -] 0.39 and 6.38 [+ or -] 1.59 [micro]g/ml were observed in ethyl acetate and chloroform fractions of root, being considered as strong free radical scavenging potentials. Whereas the [IC.sub.50] values of methanolic extract n-butanol and n-hexane fractions were 14.94 [+ or -] 3.54, 13.74 [+ or -] 2.71, and 21.49 [+ or -] 6.26, respectively, with weak antioxidant activities (Table 1); the aqueous fraction was inactive in initial screening (data not shown).

Furthermore, the stem crude extract and fractions with the [IC.sub.50] values 3.44 [+ or -] 0.69, 2.73 [+ or -] 0.84, and 2.69 [+ or -] 0.26 [micro]g/ml were documented in aqueous, ethyl acetate, and n-butanol fractions, while methanol extract was inactive (data not shown). However, the n-hexane and chloroform fractions of stem showed [IC.sub.50] values of 13.92 [+ or -] 6.04 and 22.73 [+ or -] 6.92 [micro]g/ml (Table 2). In comparison, both root and stem almost have same antioxidative potential. The growing interest in the replacement of synthetic food antioxidants with natural ones has been fostered research on plant sources and screening of raw materials to identify new antioxidants [22,23]. On the other hand, the antioxidant activities of the methanol extract of E. gerardiana (leaf) with [IC.sub.50] value 13.30 [+ or -] 0.6 [micro]g/ml showed highest free radical scavenging activities [14], which is in line with the present results; the methanol extracts of E. gerardiana (root and stem) showed antioxidant activities with [IC.sub.50] values 14.94 [+ or -] 3.54 and 22.73 [+ or -] 6.92 [micro]g/ml, respectively (Tables 1 and 2); the difference may be because these parts contain different percentage of bioactive compounds. Hence, other ephedra species such as E. laristanica and E. sarcocarpa have been studied for natural antioxidant compounds [2,13]. In light of the these results comparatively overall aqueous, ethyl acetate, and n-butanol fractions of stem of E. gerardiana might be used as strong antioxidative drug while chloroform fractions of root are also the most applied source of antioxidant.

3.2. Antifungal Activity. Based on strong antioxidant potentials, the methanolic crud extract and their fraction were evaluated for antifungal activities against A. niger and A. flavus. Hence, interesting phenomena have been reported; neither crude extract nor any fraction showed activities against used fungal strains as shown in Table 3. The chemical crude extracts of various medicinal plants other than E. gerardiana showed significant antifungal activity against aspergillus species [24,25], while present chemicals crude extracts inactive against aspergillus species were observed in the present investigation. Similarly, methanol extract of E. procera wild plant significantly showed highest antifungal activity against Candida albicans [4] and acetonitrile extracts of E. alata exhibited themost potent effects against Aspergillus fumigatus [26].

3.3. Antibacterial Activity. In order to further investigate the crude extracts and fractions for antibacterial activities, the root extract showed prominent zone of inhibition against the gram positive and gram negative bacterial strains. The highest zones of inhibition (mm) 13.3 [+ or -] 2.08 and 14.3 [+ or -] 1.53 mm were documented in chloroform fraction against B. atrophaeus and B. subtilis although n-Butanol fraction also showed 14 [+ or -] 1 and 12 [+ or -] 1 mm zone of inhibition (mm) against the same strains. Similarly ethyl acetate fraction with 12.7 [+ or -] 1.53 and 13.7 [+ or -] 1.53 mm zone of inhibition (mm) against K. pneumonia and P. aeruginosa strain revealed 11.7 [+ or -] 1.53 and 9.7 [+ or -] 1.53 mm zone of inhibition against B. atrophaeus and B. subtilis bacterial strains. The aqueous fraction showed 13 [+ or -] 1 mm zone of inhibition against B. atrophaeus and 9 [+ or -] 1 mm against K. pneumonia while the same fraction showed no activity against P. aeruginosa. Comparatively, the methanolic extract showed average activities against both gram positive and gram negative bacterial strains as compared to the other fractions (Figure 2).

On the other hand, methanolic crude extract of stem showed 13.3 [+ or -] 1.53 zone of inhibition against B. atrophaeus, whereas, n-hexane fraction showed the same zone of inhibition against the B. atrophaeus but 12 [+ or -] 1, 12.3 [+ or -] 0.58 mm against B. atrophaeus and K. pneumonia. Ethyl acetate fraction was more active throughout all fractions against both gram positive and gram negative bacteria 13 [+ or -] 1, 12.3 [+ or -] 2.08, 12.7 [+ or -] 1.53, and 10.3 [+ or -] 1 mm. The n-butanol fraction showed the activity 9 [+ or -] 1mm against B. atrophaeus and showed 9.7 [+ or -] 1 mm zone of inhibition against P. aeruginosabut no activities were observed against B. subtilis and K. pneumonia. Similarly aqueous extracts showed 9.3 [+ or -] 0.58 mm zone of inhibition against B. atrophaeus while they were inactive against the other three bacterial strains, that is, B. subtilis, K. pneumonia, and P. aeruginosa (Figure 3). Plants of the genus ephedra have traditionally been used by indigenous people for a variety of medicinal purposes, including treatment of asthma, hay fever, and common cold [27]. The methanol extract of whole plant E. gerardiana exhibited maximum antibacterial activity against Escherichia coli (2.57 mm) at 15mg/ml compared with the other two bacterial strains such as Staphylococcus aureus and P. aeruginosa [12]. In comparison, the E. gerardiana (root and stem) showed the highest antibacterial activity against most of chosen microorganisms; in regard to our test it seems that the plant chloroform fraction of root significantly revealed antibacterial potential against B. atrophaeus and B. subtilis (Figure 2). In contrast, the aqueous fraction of stem was found to be inactive against B. subtilis, K. pneumonia, and P. aeruginosa (Figure 3) as compared to the ethanol extract of E. gerardiana (leaf) which also showed prominent zone of inhibition against E. coli, S. aureus, and P. aeruginosa while being inactive against Bacillus subtilis [14]. The current data showed that the root and stem crude extracts of E. gerardiana contain antibacterial compounds.

4. Conclusion

Biological active compound from plant material is mostly dependent on the type of the solvent used in the extraction procedure; in the present study E. gerardiana extract and fraction possess antioxidant and antibacterials activities; this might be helpful in preventing or slowing the progress of various oxidative stresses and against pathogenic bacterial strains. Thus, they could be potential candidates for pharmaceutical drugs industries. Further investigation on the isolation and identification of antioxidant and antibacterial component in the plant may lead to chemical entities with potential for clinical use.

https://doi.org/10.1155/2017/4040254

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

Aman Khan executed experiment, Gul Jan helped in manuscript writing, Afsar Khan supervised the experiment, and Muhammad Danish, Farzana Gul Jan, and Ali Bahadur analyzed data. All authors discussed results of the manuscript.

Acknowledgments

The authors are acknowledging the Higher Education Commission (HEC) in Pakistan for providing financial support.

References

[1] M. R. Awan, Z. Iqbal, S. M. Shah et al., "Studies on traditional knowledge of economically important plants of Kaghan Valley, Mansehra District, Pakistan," Journal of Medicinal Plants Research, vol. 5, no. 16, pp. 3958-3967, 2011.

[2] A. Rustaiyan, K. Javidnia, M. H. Farjam, F. Aboee-Mehrizi, and E. Ezzatzadeh, "Antimicrobial and antioxidant activity of the Ephedra sarcocarpa growing in Iran," Journal of Medicinal Plants Research, vol. 5, no. 17, pp. 4251-4255, 2011.

[3] N. Kakiuchi, K. Inoue, Y. Kurita, K. Ohkubo, Y. Tsuda, and M. Mikage, "Survey of Ephedra resources in the Northern Areas of Pakistan and their genetic diversity," Journal of Natural Medicines, vol. 61, no. 3, pp. 357-365, 2007.

[4] A. Parsaeimehr, E. Sargsyan, and K. Javidnia, "A comparative study of the antibacterial, antifungal and antioxidant activity and total content of phenolic compounds of cell cultures and wild plants of three endemic species of Ephedra," Molecules, vol. 15, no. 3, pp. 1668-1678, 2010.

[5] C. E. Evans, A. Banso, andO. A. Samuel, "Efficacy of some nupe medicinal plants against Salmonella typhi: an in vitro study," Journal of Ethnopharmacology, vol. 80, no. 1, pp. 21-24, 2002.

[6] S. F. S. A. Rahman, K. Sijam, and D. Omar, "Antibacterial activity of the crude extract of Piper sarmentosum against Pseudomonas fuscovaginae," International Journal of Applied Biology and Pharmaceutical Technology, vol. 7, no. 1, pp. 67-72, 2016.

[7] M. S. I. Bakhtiar, M. Shahriar, R. Akhter, and M. A. Bhuiyan, "In vitro antioxidant activities of the whole plant extract of Chrozophora prostrata (dalz.)," Annals of Biological Research, vol. 6, pp. 19-26, 2015.

[8] P. Sathiyamoorthy, H. Lugasi-Evgi, P. Schlesinger et al., "Screening for cytotoxic and antimalarial activities in desert plants of the Negev and Bedouin market plant products," Pharmaceutical Biology, vol. 37, no. 3, pp. 188-195, 1999.

[9] A. R. Tricker, C.-D. Wacker, and R. Preussmann, "2-(N-nitroso-N- methylamino)propiophenone, a direct acting bacterialmutagen found in nitrosated Ephedra altissima tea," Toxicology Letters, vol. 38, no. 1-2, pp. 45-50, 1987.

[10] S. Al-Khalil, A. Alkofahi, D. El-Eisawi, and A. Al-Shibib, "Transtorine, a new quinoline alkaloid from Ephedra transitoria," Journal of Natural Products, vol. 61, no. 2, pp. 262-263, 1998.

[11] G. E. Feresin, A. Tapia, S. N. Lopez, and S. A. Zacchino, "Antimicrobial activity of plants used in traditional medicine of San Juan province, Argentine," Journal of Ethnopharmacology, vol. 78, no. 1, pp. 103-107, 2001.

[12] C. Walter, Z. K. Shinwari, I. Afzal, and R. N. Malik, "Antibacterial activity in herbal products used in Pakistan," Pakistan Journal of Botany, vol. 43, pp. 155-162, 2011.

[13] A. Rustaiyan, K. Javidnia, M. H. Farjam, M. K. Mohammadi, and N. Mohammadi, "Total phenols, antioxidant potential and antimicrobial activity of the methanolic extracts of Ephedra laristanica," Journal of Medicinal Plant Research, vol. 5, no. 24, pp. 5713-5717, 2011.

[14] G. P. Kumar and S. B. Singh, "Antibacterial and antioxidant activities of ethanol extracts from trans Himalayan medicinal plants," Journal of Applied Sciences, vol. 3, no. 2, pp. 53-57, 2011.

[15] M. Sengul, H. Yildiz, N. Gungor, B. Cetin, Z. Eser, and S. Ercisli, "Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants," Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 1, pp. 102-106, 2009.

[16] A. Rahman, M. M. Rahman, M. M. I. Sheik, M. M. Rahman, S. M. Shadli, and M. F. Alam, "Free radical scavenging activity and phenolic content of Cassia sophera L.," African Journal of Biotechnology, vol. 7, no. 10, pp. 1591-1593, 2008.

[17] S. D. Jacinto, E. F. Ramos, A. P. T. Siguan, and R. J. C. Canoy, "Determining the antioxidant property of plant extracts: a laboratory exercise," Asian Journal of Biology Education, vol. 5, pp. 22-25, 2011.

[18] F. Pourmorad, S. J. Hosseinimehr, and N. Shahabimajd, "Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants," African Journal of Biotechnology, vol. 5, no. 11, pp. 1142-1145, 2006.

[19] P. Veeru, M. P. Kishor, and M. Meenakshi, "Screening of medicinal plant extracts for antioxidant activity," Journal of Medicinal Plants Research, vol. 3, no. 8, pp. 608-612, 2009.

[20] R. C. Jagessar, A. Mohamed, and G. Gomes, "An evaluation of the antibacterial and antifungal activity of leaf extracts of Momordica charantia against Candida albicans, Staphylococcus aureus and Escherichia coli," Nature and Science, vol. 6, no. 1, pp. 1-14, 2008.

[21] M. Nisar, W. A. Kaleem, M. Qayum et al., "Biological screening of Zizyphus oxyphylla Edgew stem," Pakistan Journal of Botany, vol. 43, no. 1, pp. 311-317, 2011.

[22] S. E. Lee, H. J. Hwang, J.-S. Ha, H.-S. Jeong, and J. H. Kim, "Screening of medicinal plant extracts for antioxidant activity," Life Sciences, vol. 73, no. 2, pp. 167-179, 2003.

[23] M. Haq, W. Sani, A. B. M. S. Hossain, R. M. Taha, and K. M. Monneruzzaman, "Total phenolic contents, antioxidant and antimicrobial activities of Bruguiera gymnorrhiza," Journal of Medicinal Plants Research, vol. 5, no. 17, pp. 4112-4118, 2011.

[24] E. Schuster, N. Dunn-Coleman, J. C. Frisvad, and P. Van Dijck, "On the safety of Aspergillus niger--a review," Applied Microbiology and Biotechnology, vol. 59, no. 4-5, pp. 426-435, 2002.

[25] P.-H. Chuang, C.-W. Lee, J.-Y. Chou, M. Murugan, B.-J. Shieh, and H.-M. Chen, "Anti-fungal activity of crude extracts and essential oil of Moringa oleifera Lam," Bioresource Technology, vol. 98, no. 1, pp. 232-236, 2007.

[26] S. Ghanem and U. I. A. El-Magly, "Antimicrobial activity and tentative identification of active compounds from the medicinal Ephedra alata male plant," Journal of Taibah University Medical Sciences, vol. 3, no. 1, pp. 7-15, 2008.

[27] E. A. Abourashed, A. T. El-Alfy, I. A. Khan, and L. Walker, "Ephedra in perspective--a current review," Phytotherapy Research, vol. 17, no. 7, pp. 703-712, 2003.

Aman Khan, (1,2) Gul Jan, (3) Afsar Khan, (4) Farzana Gul Jan, (3) Ali Bahadur, (1,2) and Muhammad Danish (1)

(1) Department of Botany, Hazara University, Mansehra, Pakistan

(2) School of Life Science, Lanzhou University, Lanzhou, China

(3) Department of Botany, Abdul Wali Khan University, Mardan, Pakistan

(4) Department of Chemistry, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan

Correspondence should be addressed to Aman Khan; aman khan566@yahoo.com

Received 4 February 2017; Revised 12 March 2017; Accepted 30 March 2017; Published 12 April 2017

Academic Editor: Abir El-Alfy

Caption: Figure 1: Study area, the plant was collected from area ([DELTA]) as shown in map.

Caption: Figure 2: Zone of inhibition of crude methanolic extract and their fractions of E. gerardiana (root) of bacterial strains.

Caption: Figure 3: Zone of inhibition of crude methanolic extract and their fractions of E. gerardiana (stem) of bacterial strains. Key: MeOH: methanol extract; n-Hex: n-Hexane fraction; CH[Cl.sub.3]: chloroform fraction; EtOAc: ethyl acetate fraction; n-BuOH: n-butanol fraction; [H.sub.2]O: aqueous fraction; Az: Azithromycin; and Tet: tetracycline).
Table 1: Antioxidant activities of crude methanolic extract and
fractions of E. gerardiana (root).

Extract/fraction                      [IC.sub.50] [+ or -] STD
                                                 [micro]g/ml

Methanolic extract                             14.94 [+ or -] 3.54
H-hexane fraction                              21.49 [+ or -] 6.26
Chloroform fraction                             6.38 [+ or -] 1.59
Ethyl acetate fraction                          2.96 [+ or -] 0.39
n-Butanol fraction                             13.74 [+ or -] 2.71
3-Tert-butyl-4-hydroxyanisol (TBH)               1.2 [+ or -] 0.1

Table 2: Antioxidant activities of E. gerardiana (stem) fractions.

Extract/fraction            [IC.sub.50] [+ or -] STD [micro]g/ml

n-Hexane fraction                   13.92 [+ or -] 6.04
Chloroform fraction                 22.73 [+ or -] 6.92
Ethyl acetate fraction               2.73 [+ or -] 0.84
n-Butanol fraction                   2.69 [+ or -] 0.26
Aqueous fraction                     3.44 [+ or -] 0.69
Propyl gallate                        1.6 [+ or -] 0.05

Table 3: Antifungal activities of E. gerardiana (root and stem) of
crude methanolic extract and fractions.

Extract/fraction                A. flavus          A. niger

Methanolic extract                 --                 --
n-Hexane fraction                  --                 --
Chloroform fraction                --                 --
Ethyl acetate fraction             --                 --
n-Butanol fraction                 --                 --
Fluconazole                 21.4 [+ or -] 0.5   29 [+ or -] 0.0
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Khan, Aman; Jan, Gul; Khan, Afsar; Jan, Farzana Gul; Bahadur, Ali; Danish, Muhammad
Publication:Evidence - Based Complementary and Alternative Medicine
Article Type:Report
Geographic Code:9PAKI
Date:Jan 1, 2017
Words:3909
Previous Article:[sup.1]H NMR-Based Metabonomic Study of Functional Dyspepsia in Stressed Rats Treated with Chinese Medicine Weikangning.
Next Article:Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |